文献速递骨肌CTMR

病灶内宏观脂肪的存在能否排除恶性?对613例组织学证实的恶性骨病变的分析

Does the presence of macroscopic intralesional fat exclude malignancy? An analysis of 613 histologically proven malignant bone lesions.
PubMed 文献 · Eur Radiol · 2024-03-15

回顾性分析2005年12月至2021年9月在一家三级中心连续进行的613例非脊柱骨病变CT引导下空心针活检,所有恶性病变影像被复习,由两名独立读者用CT HU测量(平均HU < -30)和MRI定性评估病灶内宏观脂肪。仅3例(0.5%)显示宏观脂肪,读者间一致性优秀,提示恶性骨病变中宏观脂肪罕见。

要点

  • 恶性骨病变中CT或MRI检出病灶内宏观脂肪仅3/613例(0.5%)。
  • CT适合评估以溶骨为主的病变中的宏观脂肪,MRI可能更适合混合溶骨硬化或浸润性病变。
  • 宏观脂肪在恶性骨肿瘤中罕见,其存在可辅助骨病变诊断思路。

核心结论

  • 恶性病变在CT或MRI上很少含宏观病灶内脂肪。
  • CT能有效检测以溶骨为主的病变中的宏观病灶内脂肪,MRI可能更适合评估含混合溶骨和硬化成分的不均匀和浸润性病变。

研究设计与样本

  • 回顾性分析2005年12月至2021年9月在一家三级中心连续进行的CT引导下空心针活检的非脊柱骨病变。
  • 共纳入613例组织学证实的恶性骨病变患者(平均年龄62.9岁,范围19-95岁,47.6%女性),其中212例有额外MRI图像。
  • 两名独立读者用圆形感兴趣区在CT上测量病灶内脂肪密度(平均HU < -30),并对部分患者MRI定性评估宏观病灶内脂肪信号。
  • 读者间一致性用Cronbach's alpha和组内相关系数评估。

关键影像表现/征象

  • 仅3例(0.5%)在CT或MRI上显示宏观病灶内脂肪。
  • 1例转移性前列腺癌在CT上显示宏观病灶内脂肪密度。
  • 2例分别在软骨肉瘤和骨肉瘤的MRI上显示宏观病灶内脂肪信号。

诊断标准与关键数值

  • CT上病灶内脂肪密度定义为平均HU < -30。
  • 读者间一致性优秀:Cronbach's alpha 0.95-0.98,组内相关系数0.90-0.97。

临床应用与阅片要点

  • 恶性骨病变中宏观病灶内脂肪罕见,检出时不能据此排除恶性。
  • 评估以溶骨为主的病变时CT有效检测宏观脂肪;评估混合溶骨硬化或浸润性病变时MRI可能更优。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To determine if macroscopic intralesional fat detected in bone lesions on CT by Hounsfield unit (HU) measurement and on MRI by macroscopic assessment excludes malignancy.

MATERIALS AND METHODS: All consecutive CT-guided core needle biopsies (CNB) of non-spinal bone lesions performed at a tertiary center between December 2005 and September 2021 were reviewed. Demographic and histopathology data were recorded. All cases with malignant histopathology were selected, and imaging studies were reviewed. Two independent readers performed CT HU measurements on all bone lesions using a circular region of interest (ROI) to quantitate intralesional fat density (mean HU < -30). MRI images were reviewed to qualitatively assess for macroscopic intralesional fat signal in a subset of patients. Inter-reader agreement was assessed with Cronbach's alpha and intraclass correlation coefficient.

RESULTS: In 613 patients (mean age 62.9 years (range 19-95 years), 47.6% female), CT scans from the CNB of 613 malignant bone lesions were reviewed, and 212 cases had additional MRI images. Only 3 cases (0.5%) demonstrated macroscopic intralesional fat on either CT or MRI. One case demonstrated macroscopic intralesional fat density on CT in a case of metastatic prostate cancer. Two cases demonstrated macroscopic intralesional fat signal on MRI in cases of chondrosarcoma and osteosarcoma. Inter-reader agreement was excellent (Cronbach's alpha, 0.95-0.98; intraclass correlation coefficient, 0.90-0.97).

CONCLUSION: Malignant lesions rarely contain macroscopic intralesional fat on CT or MRI. While CT is effective in detecting macroscopic intralesional fat in primarily lytic lesions, MRI may be better for the assessment of heterogenous and infiltrative lesions with mixed lytic and sclerotic components.

CLINICAL RELEVANCE STATEMENT: Macroscopic intralesional fat is rarely seen in malignant bone tumors and its presence can help to guide the diagnostic workup of bone lesions.

KEY POINTS: • Presence of macroscopic intralesional fat in bone lesions has been widely theorized as a sign of benignity, but there is limited supporting evidence in the literature. • CT and MRI are effective in evaluating for macroscopic intralesional fat in malignant bone lesions with excellent inter-reader agreement. • Macroscopic intralesional fat is rarely seen in malignant bone lesions.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zandee van Rilland ED, Yoon SY, Garner HW, et al. Does the presence of macroscopic intralesional fat exclude malignancy? An analysis of 613 histologically proven malignant bone lesions. Eur Radiol. 2024. PMID: 38488967. doi:10.1007/s00330-024-10687-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。